The 45.3% of participants on the highest dose losing 30% or more of their body weight is the figure that has generated the most clinical discussion globally
Even at low doses, muscle loss, nutritional deficiencies, and rebound weight gain remain possible if not paired with supportive strategies like: In short, microdosing Ozempic is an emerging and somewhat experimental approach
R., Cornell, K
doi: 10.3390/nu12082178 Summary Keywords insulin resistance, L-carnitine, lipid metabolism, MASLD, mitochondrial function Citation Chen C, Zou J, Li L, Liu S, Liu Z, Yao L, Peng P, Liang J, Chen Z, Huang H and Huang J (2026) Lcarnitine in metabolic dysfunction-associated steatotic liver disease: mechanisms and therapeutic potential